Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
Status:
Completed
Trial end date:
2017-09-07
Target enrollment:
Participant gender:
Summary
This is a non-randomized, 2-part, open-label, drug-drug interaction (DDI) study to evaluate
the effect of concomitant administration of itraconazole or rifampin on the pharmacokinetics
and safety of EDP-305 in healthy human volunteers.